← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $550K of BioMarin Pharmaceutical Inc.

Sold$549,523
$91.59Price
6,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Tue, Jan 8. Filed Thu, Jan 10, 6:50 PM ET, after the close. Not investment advice.